MDIC’s 5^th Annual Public Forum will feature two panels focusing on the National Evaluation System for health Technology Coordinating Center (NESTcc) on September 5, 2018.  NESTcc Executive Director Rachael L. Fleurence, PhD, will moderate a General Session focused on advances in developing the Coordinating Center over the last year with key insights from Governing Committee members.  Following this, attendees are encouraged to join NESTcc for a Breakout Session on its test-case initiative, moderated by Owen Faris, PhD, Clinical Trials Director at the Office of Device Evaluation, Center for Devices and Radiological Health (CDRH), U.S. Food and Drug Administration (FDA).

General Session – Kathleen Blake, MD, MPH, will describe the value of NESTcc for stakeholder groups, with special emphasis on clinicians.  Interim Governing Committee Chair Michelle McMurry-Heath, MD, PhD, will share her vision for the role of NESTcc in opening the front door to targeted test-case initiatives while Jeffrey Shuren, MD, JD, will discuss the role of NESTcc in addressing FDA pre- and post-market priorities.

Breakout Session – Lesley Curtis, PhD, MS, and Joe Drozda, MD, FACC, will share insights as Network Collaborators leading test-case projects, including lessons learned and the benefits of working with NESTcc.  Dr. Curtis will also provide insights as the Chair of the NESTcc Data Quality Committee.  Paul Coplan, ScD, MBA, FISPE, will provide an industry perspective on the value of the NESTcc test-case initiative.

Register for the 2018 MDIC Annual Public Forum here.